Post-effective amendment to a registration statement that is not immediately effective upon filing

Earnings (Loss) per Share - Computation of net loss per share (Details)

v3.22.2.2
Earnings (Loss) per Share - Computation of net loss per share (Details) - P3 Health Partners Inc. - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 02, 2021
Dec. 31, 2020
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Net loss attributable to Class A common stockholders - Diluted $ (57,937,929) $ (903,105,939) $ (29,464,410) $ (24,650,712) $ (963,896,193) $ (54,115,119) $ (146,399,938) $ (31,411,542) $ (41,971,558)
Add: Net loss and tax effect attributable to Non-controlling interest (47,856,729) (748,755,990)     (798,968,740)        
Net Loss Attributable to Class A Common Stockholders - Basic (10,081,200) (154,349,949)     (164,927,453)        
Net Loss Attributable to Class A Common Stockholders - Diluted $ (10,081,200) $ (903,105,939)     $ (963,896,193)        
Weighted Average Class A Common Shares Outstanding - Basic 41,578,890 41,578,890     41,578,890        
Weighted Average Class A Common Shares Outstanding - Diluted 41,578,890 242,052,756     240,361,754        
Loss per share attributable to Class A common shareholders - Basic $ (0.24) $ (3.71) [1]   $ (3.97) [1]      
Loss per share attributable to Class A common shareholders - Diluted $ (0.24) $ (3.73) [1]   $ (4.01) [1]      
[1] ) The Company analyzed the calculation of net loss per member unit for predecessor periods prior to the Business Combinations and determined that it resulted in values that would not be meaningful to the users of these consolidated financial statements. Therefore, net loss per member unit information has not been presented for predecessor periods prior to the Business Combinations on December 3, 2021.